Cuprina Holdings (Cayman) (NASDAQ:CUPR) Stock Price Up 49.3% – Should You Buy?

Shares of Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) were up 49.3% during trading on Thursday . The stock traded as high as $3.70 and last traded at $3.30. Approximately 3,155,123 shares traded hands during trading, an increase of 2,429% from the average daily volume of 124,752 shares. The stock had previously closed at $2.21.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Cuprina Holdings (Cayman) in a report on Friday, April 24th. One analyst has rated the stock with a Sell rating, According to MarketBeat, Cuprina Holdings (Cayman) currently has an average rating of “Sell”.

Cuprina Holdings (Cayman) Trading Up 49.3%

The firm has a 50-day moving average price of $2.54. The company has a debt-to-equity ratio of 0.07, a current ratio of 2.35 and a quick ratio of 2.35.

Cuprina Holdings (Cayman) (NASDAQ:CUPR) last posted its earnings results on Monday, April 27th. The company reported ($0.40) EPS for the quarter. The business had revenue of $0.01 million for the quarter.

About Cuprina Holdings (Cayman)

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. We believe we will be able to build upon and leverage such expertise to develop innovative cosmeceutical products in the future.